STEPHANIE BORK: Open Payments
NPI 1831537018 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 9 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $2,614 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $469 |
| AstraZeneca Pharmaceuticals LP | 3 | $298 |
| United Therapeutics Corporation | 1 | $128 |
Products named: FASENRA, DUPIXENT, BREZTRI, WAYRILZ.
Industry payments across PA — which companies pay providers there.
